JP2011500596A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500596A5
JP2011500596A5 JP2010529085A JP2010529085A JP2011500596A5 JP 2011500596 A5 JP2011500596 A5 JP 2011500596A5 JP 2010529085 A JP2010529085 A JP 2010529085A JP 2010529085 A JP2010529085 A JP 2010529085A JP 2011500596 A5 JP2011500596 A5 JP 2011500596A5
Authority
JP
Japan
Prior art keywords
methyl
phenyl
triazin
trifluoromethyl
methylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010529085A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011500596A (ja
JP5411867B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/079525 external-priority patent/WO2009049165A1/en
Publication of JP2011500596A publication Critical patent/JP2011500596A/ja
Publication of JP2011500596A5 publication Critical patent/JP2011500596A5/ja
Application granted granted Critical
Publication of JP5411867B2 publication Critical patent/JP5411867B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010529085A 2007-10-11 2008-10-10 新規ｓＥＨ阻害剤およびそれらの使用 Expired - Fee Related JP5411867B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97916407P 2007-10-11 2007-10-11
US60/979,164 2007-10-11
PCT/US2008/079525 WO2009049165A1 (en) 2007-10-11 2008-10-10 Novel seh inhibitors and their use

Publications (3)

Publication Number Publication Date
JP2011500596A JP2011500596A (ja) 2011-01-06
JP2011500596A5 true JP2011500596A5 (enExample) 2011-11-24
JP5411867B2 JP5411867B2 (ja) 2014-02-12

Family

ID=40549593

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010529085A Expired - Fee Related JP5411867B2 (ja) 2007-10-11 2008-10-10 新規ｓＥＨ阻害剤およびそれらの使用

Country Status (5)

Country Link
US (1) US8008483B2 (enExample)
EP (1) EP2209376B1 (enExample)
JP (1) JP5411867B2 (enExample)
ES (1) ES2404580T3 (enExample)
WO (1) WO2009049165A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010509233A (ja) 2006-11-03 2010-03-25 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 新規ｓＥＨ阻害剤およびそれらの使用
WO2009049157A1 (en) * 2007-10-11 2009-04-16 Smithkline Beecham Corporation Novel seh inhibitors and their use
MY152834A (en) 2009-08-18 2014-11-28 Multitest Elektronische Syst An elastic unit for clamping an electronic component and extending below an electronic component receiving volume of an align fixture
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2015003355A2 (en) * 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
UA121271C2 (uk) * 2015-12-29 2020-04-27 Пфайзер Інк. Заміщені 3-азабіцикло[3.1.0]гексани як інгібітори кетогексокінази
EA035363B1 (ru) * 2016-11-17 2020-06-02 Пфайзер Инк. Замещенные 3-азабицикло[3.1.0]гексаны в качестве ингибиторов кетогексокиназы
EP4308555A4 (en) * 2021-03-18 2025-07-30 Sironax Ltd RECEPTOR-INTERACTING PROTEIN-1 INHIBITORS, PREPARATIONS AND USES THEREOF

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255704B (it) * 1992-09-30 1995-11-10 Boehringer Mannheim Italia Ammine eterocicliche utili nella terapia dell'asma e dell'infiammazione delle vie aeree
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
KR100581309B1 (ko) * 2002-02-05 2006-05-22 아스텔라스세이야쿠 가부시키가이샤 2,4,6-트리아미노-1,3,5-트리아진 유도체
US20050197350A1 (en) 2003-03-31 2005-09-08 Taisho Pharmaceutical Co., Ltd. Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
WO2005028467A1 (en) 2003-09-15 2005-03-31 Anadys Pharmaceuticals, Inc. Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds
JP2007126454A (ja) * 2005-10-06 2007-05-24 Taisho Pharmaceut Co Ltd アニリド誘導体
JP2009528992A (ja) * 2006-02-16 2009-08-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 可溶性エポキシド加水分解酵素阻害剤として有益な置換ピリジンアミン化合物
US20090111791A1 (en) * 2006-03-10 2009-04-30 Boehringer Ingelheim International Gmbh Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same
TW200808723A (en) * 2006-03-13 2008-02-16 Univ California Conformationally restricted urea inhibitors of soluble epoxide hydrolase
JP2010509233A (ja) * 2006-11-03 2010-03-25 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 新規ｓＥＨ阻害剤およびそれらの使用
WO2009049154A1 (en) 2007-10-11 2009-04-16 Smithkline Beecham Corporation NOVEL sEH INHIBITORS AND THEIR USE
WO2009049157A1 (en) 2007-10-11 2009-04-16 Smithkline Beecham Corporation Novel seh inhibitors and their use
WO2009091388A2 (en) * 2007-12-21 2009-07-23 Progenics Pharmaceuticals, Inc. Triazines and related compounds having antiviral activity, compositions and methods thereof

Similar Documents

Publication Publication Date Title
JP2011500596A5 (enExample)
JP2011500594A5 (enExample)
JP2016526561A5 (enExample)
RU2401265C2 (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
CA2663366A1 (en) Compounds and compositions as protein kinase inhibitors
JP2004534010A5 (enExample)
PE20091891A1 (es) Inhibidores de proteina activadora de la 5-lipoxigenasa (flap)
JP2013510876A5 (enExample)
ME00427B (me) N-supstituisani hidroksipiramidinon karboksamidni inhibitori hiv integraze
JP2010538076A5 (enExample)
RU2013143028A (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
JP2010515691A5 (enExample)
RU2011137399A (ru) Гетероциклическое производное
RU2017145650A (ru) Ингибиторы тирозинкиназы брутона
HRP20120240T1 (hr) Piridil piperidin antagonisti receptora za oreksin
NO20076323L (no) Kombinasjon omfattende N-{5-[4-(4-metylpiperazinometyl)-benzoylamido]-2-metyl-fenyl}-4-(3-pyridyl)-2-pyrimidinamin og en aromataseinhibitor, anvendelse av kombinasjonen samt farmasøytisk preparat
HRP20210143T1 (hr) 2-heteroaril-3-okso-2,3-dihidropiridazin-4-karboksamidi za liječenje raka
RU2003131693A (ru) Новые ингибиторы тирозин киназ
JP2009542721A5 (enExample)
AR064302A1 (es) Arilpirazoles sustitudos
HRP20220096T1 (hr) Inhibitori lizin specifične demetilaze-1
CA2585053A1 (en) Substituted n-acyl (hetero)aryl compounds as c-fms kinase inhibitors
PE20120626A1 (es) Composiciones farmaceuticas que comprende nilotinib
RU2011149360A (ru) Замещенные фенилмочевины и фениламиды в качестве лигандов ваниллоидных рецепторов
JP2016503009A5 (enExample)